Prof. Francesco Bedogni
Professor of Hemodynamics and the Interventional Cardiology
Prof. Francesco Bedogni has been Director of the Clinical, Interventional Cardiology and Coronary Intensive Care Units (CICU) at IRCCS Policlinico San Donato in Milan, Italy, since July 2015. From 1998 to 2015, he was Director of the Coronary Intensive Care Unit (UCIC), Hemodynamics and Interventional Radiology at the Sant'Ambrogio Clinical Institute in Milan.
Since 2013, he has been an Adjunct Professor in the Schools of Specialisation in Cardiology at the University of Milan and Cardiac Surgery at the Vita-Salute San Raffaele University.
Prof. Francesco Bedogni studied at the University of Padua, where he graduated in 1980 specialising in Cardiology four years later. He then continued his training abroad, attending several Hemodynamics laboratories in Toulouse and Bordeaux in France, New York, California and Wisconsin in the United States. In 1984, he worked as Assistant Professor at the Arnault Tzanck Institute of Saint Laurent du Var in Nice, where he honed his skills in Interventional Cardiology, participating in about 1,200 hemodynamic procedures including numerous Coronary Angioplasties.
Prof. Francesco Bedogni routinely collaborates with numerous public and private hospitals throughout Italy, dealing with aortic and mitral structural interventional procedures. Since 2014 he has been Proctor in Pittsburgh, Saint Louis and Minneapolis (United States) for the Food and Drug Administration (FDA). He is currently European proctor for Transcatheter Aortic Valve Implantation (TAVI) and Percutaneous Mitral Repair (Mitraclip) for international companies at the forefront of this field (Medtronic, Boston Scientific, Abbott and Terumo).
He has authored more than 320 scientific articles and abstracts and his contributions appear in prestigious journals such as Circulation, Journal of the American College of Cardiology, European Heart Journal, American Journal of Cardiology, QJM, Cardiology, Catheterization and Cardiovascular Interventions, and Coronary Artery Disease.